Obesity Trial, Recruiting NCT07429136 Sponsor: Amsterdam University of Applied Sciences Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT07429136
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 55 or older.
  • People who are classified as obese, meaning a BMI over 30, or a BMI over 27 combined with a waist measurement above 88 cm for women or 102 cm for men.
  • People who live independently at home, not in a hospital, nursing home, or other health facility.
  • People who are willing to have their general practitioner informed that they are taking part in the study.
  • People who are willing to sign a written consent form agreeing to take part.
  • People who are willing to follow the study's rules and schedule.
  • People whose participation is approved by the study physician.

Who may not be able to join:

  • People who are unable to understand the Dutch language.
  • People with significant cognitive (thinking and memory) difficulties, based on a specific memory test score (confirm with trial site).
  • People who receive nutrition directly into a vein (either fully or partially) rather than eating normally.
  • People who, in the opinion of the study investigator, have a problem with alcohol or drug use.
  • People who are currently enrolled in a structured rehabilitation program or another research study.
  • People who are receiving palliative (end-of-life comfort) care or who have a life expectancy of three months or less.
  • People who follow a vegetarian or vegan (fully plant-based) diet.
  • People who have had weight-loss (bariatric) surgery.
  • People currently receiving medical treatments that could interfere with this study, such as weight-loss medications or cancer treatments including chemotherapy or immunotherapy.
  • People who have a physical disability that prevents them from meeting standard daily exercise guidelines for adults.
  • People who have a holiday planned during the study period that would mean missing group or individual sessions for more than three weeks.
  • People diagnosed with unstable heart disease, severe heart failure, uncontrolled high blood pressure, or uncontrolled irregular heartbeat, if the study physician determines this would interfere with the dietary treatment (confirm with trial site).
  • People diagnosed with a degenerative brain or memory condition, if the study physician determines this would interfere with the dietary treatment (confirm with trial site).
  • People diagnosed with kidney failure, if the study physician determines this would interfere with the dietary treatment (confirm with trial site).
  • People with severe chronic lung disease (COPD at an advanced stage), if the study physician determines this would interfere with the dietary treatment (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Peter Weijs, Amsterdam University of Applied Sciences

Phone: +31623492734

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Amsterdam University of Applied Sciences
Registry
ClinicalTrials.gov
Start date
13 August 2024
Est. completion
1 October 2026

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Feasibility of high plant-based protein intake while simultaneously striving for weight loss and increased protein intake

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov